Showing results (2151-2160 of 3,896) with videos related to

Sort By:
Pageof 390
Disease Markers|December 27, 2021
Plasma S-Adenosylmethionine Is Associated with Lung Injury in COVID-19Evgeny Vladimirovich Kryukov, Alexander Vladimirovich Ivanov, Vladimir Olegovich Karpov, et al.
Disease Markers|December 27, 2021
miRNA-19b-3p Stimulates Cardiomyocyte Apoptosis Induced by Myocardial Ischemia Reperfusion via Downregulating PTENKe Li, Xujie Ya, Xiujuan Duan, et al.
Disease Markers|August 29, 2022
miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT InductionYingqian Zhang, Jiao Yuan, Mengfei Guo, et al.
Disease Markers|August 29, 2022
Identification of Prognostic Genes and Immune Landscape Signatures Based on Tumor Microenvironment in Lung AdenocarcinomaPengkai Han, Yunxiu Fan, Qiping Liu, et al.
Disease Markers|September 19, 2022
Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and ImmunotherapyJing Cui, Yongjie Tian, Tianhang Liu, et al.
Disease Markers|September 19, 2022
Overexpressed Thrombospondin 2 Induced Osteogenic Differentiation of Valve Interstitial Cells via Inhibition of Akt/NF-κB Signaling Pathway to Promote Calcific Aortic Valve Disease DevelopmentCheng Yu, Danna Wu, Chong Zhao, et al.
Disease Markers|September 27, 2022
KIAA0101 and IL2RA Were Identified as Core Genes in Hormone-Resistant NephropathyYing Chen, Shuyi Qian, Yinyin Chen, et al.
Disease Markers|September 23, 2022
Exosomes Derived from Adipose Mesenchymal Stem Cells Carrying miRNA-22-3p Promote Schwann Cells Proliferation and Migration through Downregulation of PTENJianqiang Yang, Baoxin Wang, Yating Wang, et al.
Disease Markers|September 23, 2022
Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular CarcinomaYongjie Zhou, Xin Zhou, Qingxin Liu, et al.
Disease Markers|September 26, 2022
Afatinib Targeted Therapy Affects the Immune Function and Serum Levels of EGFR and Gastrin-Releasing Peptide Precursor (pro-GRP) in Patients with Non-Small-Cell Lung Cancer (NSCLC)Wei Cao, Jun Ma, Xuan Jiang, et al.
Pageof 390